Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
Bellco Capital
AddedFeb 13, 2024
UpdatedJun 28, 2026
Bellco Capital

Bellco Capital

Operating

Bellco Capital LLC: A California-based direct investment firm fostering exponential growth across diverse sectors.

Location
Los Angeles, CA, US
Founded
2004
Firm
Compare
Portfolio
Employees
Website

Bellco Capital LLC is a California-based direct investment firm founded by Rebecka Belldegrun, M.D., and Arie Belldegrun, M.D. The firm focuses on deploying capital to create and support companies with ambitions of exponential transformation across diverse sectors, including life sciences, real estate, consumer products, and media. Bellco Capital typically invests in Series A and Series B rounds, with occasional seed and private equity investments.

Notable portfolio companies include Allogene Therapeutics, ByHeart, Dewpoint Therapeutics, Hubble Contacts, IconOVir Bio, Kite Pharma, and Kronos Bio. The firm is led by key partners with significant industry expertise, particularly in life sciences. Bellco Capital emphasizes building strong relationships with its portfolio companies and offers unique value-add services to foster their growth and success.

Bellco Capital - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments9
Current Portfolio Count7
Total Portfolio Exits1

Top Investment Stages

Series A4 (44.4%)
Series B3 (33.3%)
Private Equity1 (11.1%)
Seed1 (11.1%)

Stage Mix

Series A 44%Series B 33%Private Equity 11%Seed 11%

Concentration shown as share of disclosed investments by stage.

Recent Investments

ByHeart logo

ByHeart

IconOVir Bio logo

IconOVir Bio

Dewpoint Therapeutics logo

Dewpoint Therapeutics

Aliment Capital logo

Aliment Capital

Hubble Contacts logo

Hubble Contacts

Kronos Bio logo

Kronos Bio

Allogene Therapeutics logo

Allogene Therapeutics

Kite Pharma logo

Kite Pharma

Bellco Capital - Similar Investment Firms

Belle Capital logo

Belle Capital

Marc Bell Capital logo

Marc Bell Capital

marcbell.com

Corbel Capital Partners logo

Corbel Capital Partners

corbelcap.com

Colbeck Capital Management logo

Colbeck Capital Management

colbeck-clarke.com

Breyer Capital logo

Breyer Capital

breyercapital.com

Background Capital logo

Background Capital

background.vc

Skyview Capital logo

Skyview Capital

skyviewcapital.com

Allegis Capital logo

Allegis Capital

allegiscapital.com

Mission Bay Capital logo

Mission Bay Capital

Bling Capital logo

Bling Capital

blingcap.com

Cobalt Capital logo

Cobalt Capital

cobalt.la

Foresite Capital logo

Foresite Capital

GrayBella Capital logo

GrayBella Capital

Fundamental Capital logo

Fundamental Capital

B Capital Group logo

B Capital Group

b.capital

Bellco Capital - Classification

Also Known As
  • Bellco Capital LLC
NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 6700Holding And Other Investment Offices
  • 6790Miscellaneous Investing
  • 6799Investors, Not Elsewhere Classified
Show 6 more industry codes
NAICS
  • 525000Funds, Trusts, and Other Financial Vehicles
  • 523910Miscellaneous Intermediation
  • 523940Portfolio Management and Investment Advice
SIC
  • 6000Depository Institutions
  • 6720Investment Offices
  • 6722Management Investment Offices, Open-end